Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOPIDOGREL for Percutaneous coronary intervention: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where CLOPIDOGREL was used for Percutaneous coronary intervention.

Most Reported Side Effects for CLOPIDOGREL

Side Effect Reports % Deaths Hosp.
Gastrointestinal haemorrhage 43 6.7% 15 22
Haematuria 42 6.5% 2 22
Anaemia 37 5.8% 0 30
Dyspnoea 23 3.6% 5 7
Pruritus 23 3.6% 5 9
Confusional state 22 3.4% 3 21
Haemorrhage 22 3.4% 6 8
Drug interaction 21 3.3% 6 11
Contusion 20 3.1% 1 8
Dizziness 18 2.8% 2 5
Renal failure acute 18 2.8% 2 16
Thrombocytopenia 17 2.6% 1 7
Epistaxis 15 2.3% 1 7
Pyrexia 15 2.3% 0 1
Haematoma 14 2.2% 2 11

Other Indications for CLOPIDOGREL

Product used for unknown indication (160) Myocardial ischaemia (40) Thrombosis prophylaxis (35) Coronary arterial stent insertion (33) Antiplatelet therapy (32) Cerebrovascular accident (24) Prophylaxis (22) Stent placement (20) Transient ischaemic attack (19) Coronary artery disease (18)

Other Drugs Used for Percutaneous coronary intervention

PRASUGREL (376) CLOPIDOGREL BISULFATE (356) TICAGRELOR (297) ASPIRIN (227) BIVALIRUDIN (159) CANGRELOR (94) HEPARIN (86) ABCIXIMAB (49) INVESTIGATIONAL PRODUCT (46) IODIXANOL (29)

Related Pages

CLOPIDOGREL Full Profile All Percutaneous coronary intervention Drugs CLOPIDOGREL Demographics CLOPIDOGREL Timeline